- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK Negative NSCLC in Germany
Total 23525 results
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital TuebingenNot yet recruitingNSCLCGermany, Netherlands
-
University Hospital HeidelbergDietmar Hopp StiftungRecruitingNSCLC Stage IIIB | NSCLC Stage II | NSCLC, Stage IIIAGermany
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingTNBC - Triple-Negative Breast CancerGermany
-
German Cancer Research CenterUniversity Hospital Heidelberg; National Center for Tumor Diseases, HeidelbergCompleted
-
LMU KlinikumDepartment of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich... and other collaboratorsRecruitingOncology | NSCLC, Stage III | Chemoradiotherapy | Biomarker | DurvalumabGermany
-
Goethe UniversityRecruitingNSCLC Stage IV | NSCLC Stage IIIBGermany
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
West German Study GroupCelgeneActive, not recruiting
-
University Hospital, EssenRecruiting
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AGCompletedHer2-negative Metastatic Breast Cancer | Her2-negative Locally Advanced Breast CancerGermany
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Institut für Klinische Krebsforschung IKF GmbH...AstraZeneca; Thoraxklinik-Heidelberg gGmbHRecruiting
-
Lung Cancer Group CologneTerminatedNSCLC | Lung Cancer | NSCLC Stage IV | Squamous Cell Lung Cancer | Pulmonary NeoplasmGermany
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
AstraZenecaCompletedNSCLCSweden, Bulgaria, Mexico, Russian Federation, Turkey, United Kingdom, Philippines, Malaysia, Germany, Hungary, Latvia, Lithuania, Poland, Romania, Netherlands, Norway, Argentina, Australia, Canada, Slovakia, Greece, Taiwan, Thailand, ... and more
-
Charite University, Berlin, GermanyRecruitingHead and Neck Cancer | Esophageal Cancer | NSCLC | Prostate Cancer | SCLC | Bladder Cancer | Cervix Cancer | Rectum Cancer | Other CarcinomaGermany
-
Ulf Dornseifer, MDCompletedEdema | Microcirculation | Negative-Pressure Wound Therapy | Free Flap | MacrocirculationGermany
-
University Hospital, EssenCompletedNSCLC | EGFR T790M | FDG-PETGermany
-
Valo Therapeutics OyRecruitingColorectal Cancer | Non-Small Cell Lung Cancer | Melanoma (Skin) | Myxoid Liposarcoma | Synovial Sarcoma | Triple-Negative Breast CancerGermany
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Novartis VaccinesCompletedHelicobacter Pylori InfectionGermany
-
Universität Duisburg-EssenEli Lilly and CompanyUnknown
-
GlaxoSmithKlineCompletedInfections, MeningococcalGermany
-
Prof. W. JanniActive, not recruitingHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
Maastricht University Medical CenterKU Leuven; University College, London; Erasmus Medical Center; Catholic University... and other collaboratorsActive, not recruitingNSCLC Stage IV | Metastatic DiseaseNetherlands, Belgium, United Kingdom, Germany, France, Italy
-
Technical University of MunichCompleted
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
Goethe UniversityUnknownReduction of Negative Appendectomy RateGermany
-
Valneva Austria GmbHCompleted
-
NovartisNovartis VaccinesCompletedMeningococcal InfectionGermany
-
University Hospital HeidelbergRecruiting
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
Novartis PharmaceuticalsTerminatedPrimary Hormone Receptor Negative Breast Cancer in Premenopausal WomenGermany
-
University of CologneRecruiting
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLCCompletedNon-small Cell Lung Cancer (NSCLC)Germany
-
Merck KGaA, Darmstadt, GermanyCompletedNon-Small Cell Lung Cancer (NSCLC)Germany
-
Novartis VaccinesGlaxoSmithKlineCompleted
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
University of Hamburg-EppendorfRecruitingSchizophrenia | Psychosis | Negative Symptoms With Primary Psychotic DisorderGermany
-
MerLion Pharmaceuticals GmbHCompletedDyspepsia | Gram-Negative Bacterial Infections | Helicobacter InfectionsGermany
-
University of UlmRecruitingBCR-ABL1-Negative Myeloid NeoplasmsGermany
-
University of Erlangen-Nürnberg Medical SchoolCompletedH. Pylori InfectionGermany
-
University of RegensburgUniversity Hospital Ostrava; Brno University Hospital; University Hospital, AachenRecruitingSchizophrenia | Negative Symptoms With Primary Psychotic DisorderCzechia, Germany
-
ETOP IBCSG Partners FoundationCompleted